Department of Medicine

Three Larner College of Medicine faculty-led, interprofessional group projects have been selected to receive 2022 Frymoyer Scholars funding. The three projects focus on newborn resuscitation, building an interdisciplinary gender affirming care model, and fostering excellent clinical teachers, respectively.

(JULY 15, 2022) UVM Cancer Center director Randall Holcombe, M.D., M.B.A., told the Burlington Free Press that the center, together with the Dartmouth Cancer Center and Vermonters Taking Action Against Cancer, has launched a campaign to increase screening for lung cancer — the leading cause of cancer death in Vermont and the country.

(JULY 13, 2022) As Vermonters contemplate the future of COVID-19, infectious disease expert Timothy Lahey, M.D., M.M.Sc., professor of medicine, said in an interview with WCAX-TV that there are going to be peaks and valleys during the pandemic.

On July 11, E.L. Amidon Chair and Professor of Medicine Polly Parsons, M.D., began the transition to her new role as President and CEO of the Alliance for Academic Internal Medicine (AAIM). We sat down with Dr. Parsons to reflect on her 16 years at the helm of the department, review her accomplishments and consider the department’s growth, struggles and triumphs.

More than 100 in-person and dozens of virtual participants attended the second annual Vermont Center for Cardiovascular and Brain Health (VCCBH) Symposium, held at the University of Vermont’s Davis Center June 2 to 3, 2022. The VCCBH, one of three National Institutes of Health Center of Biomedical Research Excellence-funded programs at UVM, is co-directed by Mary Cushman, M.D., M.Sc., professor and vice chair for emerging researchers in the Department of Medicine, and Mark Nelson, Ph.D., University Distinguished Professor and chair of the Department of Pharmacology.